iGlobe Partners — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
C2i Genomicsc2i-genomics.comin𝕏Apr 2021 · $100MAcquired
C2i Genomics develops TrueMRD, a cancer monitoring platform that combines whole-genome sequencing with AI algorithms to build personalized tumor signatures for detecting minimal residual disease (MRD).
AI & Machine LearningBiotechHealthtechNew York, US
Asaf Zviran(Founder)inEzra Sofer(Executive Officer, Director)
BoardEli Casdin(Director)inAlex Parker(Director)Shaun Rodriguez(Director)in
Co-investorsLionBirdNFXCasdin CapitalSection 32
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.